Company intelligence / Profile preview

Master Pharm

Łódź, Łódzkie, Poland

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Master Pharm is a prominent European contract development and manufacturing organization (CDMO) that specializes in the design, formulation, and production of dietary supplements, medical devices, cosmetics, and functional foods. Based in Poland, the company provides end-to-end services from product development and laboratory testing to large-scale manufacturing and regulatory support. Formerly a publicly traded company on the Warsaw Stock Exchange, it was acquired by the Italian pharmaceutical group Procemsa in 2023.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Master Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Master Pharm.

Explore the full profile